SREBF1 and metabolic dysfunction-associated steatotic liver disease: A decreased Srebp1c expression in the MI group compared to the HFHFr group was expected in a study with mice models with liver injuries treated with NR, and another study with an experimental NAFLD rat model treated with betaine [80,108].